Smokeless Tobacco Is a Major Risk Factor for Oral Cancer in South and Southeast Asia.

Oral Dis

International Agency for Research Cancer, Lyon, France.

Published: February 2025

Objective: This review presents an overview of the current knowledge on smokeless tobacco and oral cancer, with a specific focus on South and Southeast Asia.

Method: The recent literature on the association of smokeless tobacco and oral cancer, its biological mechanisms, and policies for prevention and control, was reviewed. In addition, its role in the causation of oral cancer and allied diseases was assessed its biological mechanisms resulting in deleterious health outcomes and steps to control its use.

Results: Of the more than 360 million people who consume smokeless tobacco globally, nearly 80% reside in the region. The evidence of an association between the numerous SLT products consumed in the region and oral cancer is well established, with oral snuff and gutkha showing the strongest association. More than 4000 chemical ingredients are present in these products, many of which are involved in the intricate biological pathways leading to carcinogenesis.

Conclusion: Given the deep cultural integration of SLT products, effective control measures require multifaceted approaches that combine education, regulation, and community engagement. Collaborative efforts among governments, healthcare professionals, and communities are essential to address this urgent issue and mitigate the substantial human and economic costs.

Download full-text PDF

Source
http://dx.doi.org/10.1111/odi.15241DOI Listing

Publication Analysis

Top Keywords

oral cancer
20
smokeless tobacco
16
tobacco oral
8
biological mechanisms
8
slt products
8
oral
6
cancer
5
smokeless
4
tobacco major
4
major risk
4

Similar Publications

Aims: Osteoarthritis (OA) is a widespread chronic degenerative joint disease with an increasing global impact. The pathogenesis of OA involves complex interactions between genetic and environmental factors. Despite this, the specific genetic mechanisms underlying OA remain only partially understood, hindering the development of targeted therapeutic strategies.

View Article and Find Full Text PDF

Prospect of extracellular vesicles in tumor immunotherapy.

Front Immunol

March 2025

Department of Reproductive Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.

Extracellular vesicles (EVs), as cell-derived small vesicles, facilitate intercellular communication within the tumor microenvironment (TME) by transporting biomolecules. EVs from different sources have varied contents, demonstrating differentiated functions that can either promote or inhibit cancer progression. Thus, regulating the formation, secretion, and intake of EVs becomes a new strategy for cancer intervention.

View Article and Find Full Text PDF

Resection of advanced oral malignancies often leads to extensive composite tissue defects, which may involve skin, oral mucosa, mandible, and a significant amount of soft tissue. While the free fibula flap remains the primary choice of reconstruction, there are instances where a second flap is necessary for coverage. In such cases, the anterolateral thigh (ALT) flap is commonly employed as a second free flap.

View Article and Find Full Text PDF

Full-thickness defects of the lower lip pose a considerable challenge for reconstructive surgeons. The primary objective should be the restoration of oral sphincter competence, achieving both functionally and aesthetically favorable outcomes. For defects involving more than one-third of the lower lip, multiple locoregional flaps have been described as the optimal solution due to their color and texture match.

View Article and Find Full Text PDF

The treatment landscape for chronic lymphocytic leukemia (CLL) has expanded dramatically over the last decade, with a wide range of effective treatments now available. Clinical management of CLL varies widely depending on patient profile, meaning the optimal treatment in Arab patients, who tend to be young and often present with comorbidities, including diabetes and obesity, requires specific considerations. In the absence of regional guidelines, a group of experts from across the Gulf region and one international expert from Germany convened to discuss and agree upon a position statement for venetoclax-based fixed-duration treatment strategies for Arab patients with CLL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!